Koch, Marcus W. http://orcid.org/0000-0001-9972-5092
Mostert, Jop
Greenfield, Jamie
Liu, Wei-Qiao
Metz, Luanne
Article History
Received: 13 April 2020
Revised: 30 April 2020
Accepted: 5 May 2020
First Online: 9 May 2020
Compliance with ethical standards
:
: Dr. Koch reports personal fees and non-financial support from Biogen Idec, personal fees and non-financial support from EMD Serono, personal fees and non-financial support from Novartis, personal fees and non-financial support from Roche, and personal fees and non-financial support from Sanofi Genzyme. Dr. Mostert has nothing to disclose. Ms. Greenfield has nothing to disclose. Dr. Liu reports personal fees from EMD Serono, personal fees from Novartis, and personal fees from Sanofi Genzyme. Prof. Metz has nothing to disclose.
: All participants included in these analyses have given their written informed consent to participate in an ongoing longitudinal study of outcomes and predictors of MS, or a waiver of consent was provided by the University of Calgary’s Conjoint Health Research Ethics Board (CHREB). Ethical approval was granted by CHREB.